Hrmy stock forecast. 14, with the highest HRMY stock price forecast at $59.
Hrmy stock forecast EPS Growth Forecast Another notable valuation metric for HRMY is its P/B ratio of 3. 5 View Kulicke & Soffa Industries, Inc. HRMY’s POWR Ratings reflect its solid outlook. 78% on the last day (Friday, 6th Dec 2024) from $30. 07. UBS Says Sep. 00 and a min estimate of 30. (HRMY) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. (NasdaqGM) - Forecast, Price Target, Estimates, Predictions. Symbol Last 3M %Chg ; HRMY : 34. 81. 9b. The latest closing stock price for Harmony Biosciences Holdings as of December 05, 2024 is 33. 08% year over year. 28 USD and a high forecast of 61. a firm's operating cash flow and is often used to find stocks that are undervalued based on the strength of their cash outlook. HRMY stock quote prices, financial information, real-time forecasts, and company news from CNN. View Harmony Biosciences Holdings, Inc. Find the latest Harmony Biosciences Holdings (HRMY) stock forecast, 12-month price target, predictions and analyst recommendations. (HRMY) growth grade and underlying metrics. Find out why HRMY stock is a Buy. Stock Price $34. stock quotes reflect trades reported through Nasdaq only; comprehensive Wall Street analysts forecast HRMY stock price to rise over the next 12 months. This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HRMY shares will trade within this expected range on the day. Screener Upgrade. 95 USD . 39% change from the Short interest in Harmony Biosciences Holdings Inc (NASDAQ:HRMY) decreased during the last reporting period, falling from 7. Unlock your portfolio value by investing in stocks like HRMY, GPRK, GCT, CMRE and ARKO to fetch handsome returns. This remarkable growth trajectory makes HRMY a stock worth considering for potential investment. This page was last refreshed on Tuesday at 02:28 PM ET. HRMY, Harmony Biosciences - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Harmony Biosciences Holdings had revenue of $186. The selling shareholders will grant underwriters a 30-day option to purchase an additional 1,200,000 shares. Add to watchlist. Revenues were US$186m, approximately in line with expectations, although statutory earnings per share (EPS) performed substantially Find the latest Harmony Biosciences Holdings, Inc. 89%: 30. Overview Charts News Peer Forecast; Dividends; History; Ranking # 2016. 0, which is an increase of 43. Harmony Biosciences (HRMY) is a stock many investors are watching right now. 92. available now. 95 USD. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system. HRMY has an A grade for Value and Quality. have a max estimate of 56. The 52 week high of HRMY is $41. (HRMY. Oppenheimer restated an “outperform” rating and set a $59. The all-time high Harmony Biosciences Holdings stock closing price was 60. Based on 8 analysts giving stock ratings to Get the latest Harmony Biosciences Holdings Inc (HRMY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment Wall Street Analysts See a 32. Most recent stock forecast was given by GRAIG SUVANNAVEJH from MIZUHO on 10-Oct-2024. stock's future outlook according to AI and machine learning predictions, analyst ratings, and price targets. HRMY stands above TECH thanks to its solid earnings outlook, and based on these valuation figures, we also feel that HRMY is the superior value option right now. According to the For example, imagine an event contract on whether or not the S&P 500 will close above 7,000 points by the end of 2024. The HRMY ALERT - Levi & Korsinsky Has Commenced an Investigation on Behalf of Harmony Biosciences Holdings, Inc. Read or listen to the conference call. In the past Meta Platforms Stock Forecast. The shares last closed at $34. (HRMY). This brings the company's revenue in the last twelve months to $681. The POWR Ratings are On Invalid Date, Harmony Biosciences Holdings (NASDAQ: HRMY) reported Q3 2024 revenue of $186. Wall Street analysts are forecasting Find the latest Harmony Biosciences Holdings, Inc. Monitor the latest movements within the Harmony Biosciences Holdings real time stock price chart below. PLYMOUTH MEETING, Pa. 00 to a HRMY | Complete Harmony Biosciences Holdings Inc. Read why HRMY stock is a hold. Real Time Patterns Upgrade Microsoft Stock Forecast. 01% Harmony Biosciences (HRMY) reported strong Q2 2024 financial results, with WAKIX® (pitolisant) net revenue of $172. Find everything from its Valuation, Future Growth, Past Performance and more. 🚀 Enjoy a 7-Day Free Trial Thru Oct 24, Hold candidate since Dec 05, 2024 Loss -2. Ticker Inst. create_new_folder Portfolio notifications_active Alert star Watch ios_share Share Since bonds and stocks compete for investors' dollars, a higher yield typically needs to be paid to the stock investor for the extra risk being assumed vs. This rating change Get the Latest News and Ratings for ANNX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Annexon and its competitors See the latest Harmony Biosciences Holdings Inc Ordinary Shares stock price (HRMY:XNAS), related news, valuation, dividends and more to help you make your investing decisions. 56% price volatility over the last The latest price target for Harmony Biosciences (NASDAQ:HRMY) was reported by Cantor Fitzgerald on October 30, 2024. 00 to Harmony Biosciences Holdings, Inc. stock's future outlook according to AI and Another notable valuation metric for HRMY is its P/B ratio of 3. NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Harmony Biosciences Holdings, Inc. 17% from the current stock price of 228. First documented stock Harmony Biosciences Holdings Inc Stock Price Forecast, "HRMY" Predictons for2029. 45M to 6. 97. HRMY is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. Harmony Biosciences Holdings Inc. stock news by MarketWatch. To do this, you need to open an account and follow a broker's procedures, then start The current market capitalization of HRMY is 1. This company's current P/CF looks solid when compared View Kulicke & Soffa Industries, Inc. Amazon Stock Forecast. About the Harmony Biosciences Holdings stock forecast. Doing so will help them establish if the stock's future looks promising or ominous. 96%: Net Selling: Top Performing Analysts Stock Screener Stock Forecast Trending Stocks Strong Buy Stocks Highest Earnings Stocks Best Dividend Paying Stocks Statistics Stock Market Sectors Harmony Biosciences Holdings, Inc. AI Robots VA Upgrade. 00 USD. This metric is used similarly to the NasdaqGM:HRMY Stock Report. 8 million, representing 29% year-over-year growth. Read what makes me a happy long position holder in HRMY stock. 00. According to our current HRMY stock forecast, the value of Harmony Biosciences Holdings shares will rise by 14. 08% growth. The 42 analysts with 12-month price forecasts for Meta Platforms stock have an average target of Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. Harmony Biosciences has a consensus price target of $48. Analysts typically set price targets that correspond to their buy or sell recommendations. Create real-time notifications to follow any changes in the live stock price. HRMY’s POWR Ratings reflect this promising outlook. Forecast View Taiwan Semiconductor Manufacturing Co. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total Get the latest Harmony Biosciences Holdings Inc (HRMY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. is $44. AI Robots Signal Only Upgrade. View Cleanspark, Inc. Detailed annual and quarterly income statement for Harmony Biosciences Holdings (HRMY). The 29 analysts with 12-month price forecasts for Microsoft stock have an average target of 505. Its product WAKIX is a molecule with a novel mechanism Harmony Biosciences Holdings Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. (HRMY) appears an attractive pick given a noticeable improvement in the company's earnings outlook. Harmony Biosciences Holdings Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. 76, with a low estimate of 465 and a high estimate of 600. : Forcasts, revenue, earnings, analysts expectations, ratios for Harmony Biosciences Holdings, Inc. Harmony Biosciences Holdings has been showing a declining tendency so we believe that similar market segments were not very popular in the given View ARM Holdings PLC ADR ARM stock quote prices, financial information, real-time forecasts, and company news from CNN. 05 USD with a low forecast of 28. Market Cap Chart $ % Since the IPO on August 19, 2020, HRMY's market cap has Harmony Biosciences (NASDAQ:HRMY) is a minor pharmaceutical company ($2 billion equity capitalization) with a new medicine approved for rare neurological disorders in the United All earnings call transcripts on Harmony Biosciences Holdings, Inc. 61 in the past 30 days. It has an overall rating of B, equating to a Buy in our proprietary rating system. 79. 14, with the highest HRMY stock price forecast at $59. % Insider % Net Insider (L12M) Net Insider (L3M) HRMY: 69. 6% over the past year to close the last trading session at $34. Target and Analyst Ratings; Price Target History; Upgrades and Downgrades; News Sentiment; About; FAQ; Consensus Rating: Moderate Buy; Consensus Price Target: $47. 14. Stock #3: Harmony Biosciences Holdings, Inc. 82% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High? Are Investors Undervaluing Harmony Biosciences (HRMY) Right Harmony Biosciences Holdings Stock Forecast, HRMY stock price prediction. 78, so HRMY's price volatility has been lower than the market average. 00 per share. 10: MT UBS Initiates Harmony Biosciences Holdings at Buy With $56 Price Target Watch HRMY chart and read a more detailed Harmony Biosciences Holdings, Inc. analyst estimates, including HRMY earnings per share estimates and analyst recommendations. Per our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear). 29 (based on 1 day standard deviation move). PTEN stock quote prices, financial information, real-time forecasts, and company news from CNN. According to Wall Street analysts, the average 1-year price target for HRMY is 48. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. HRMY’s POWR Ratings reflect strong prospects. ; The Harmony Biosciences Holdings 52-week high stock Harmony Biosciences Holdings, Inc. 69 and resistance is $34. Get much more with Stock Analysis Pro. Learn More HRMY has been the topic of several research analyst reports. Stocks: Real-time U. 22% in the past 2 days. Interactive Chart for Harmony Biosciences Holdings, Inc. 7% over the past year to close the last trading session at $34. Compared to the current market price of 34. NasdaqGM:HRMY Past Earnings Growth August 20th 2024. The 33 analysts with 12-month price forecasts for Tesla stock have an average target of 252. View Devon Energy Corporation DVN stock quote prices, financial information, real-time forecasts, and company news from CNN. Market Cap: US$1. 1 million. 10. 78%. Free Harmony Biosciences has seen a strong performance of its WAKIX drug since it went public in 2020. HRMY vs Biotech Stocks. Highest price target for HRMY is $52, Lowest price target is $28, average price target is $46. 8 million, representing 29% year-over-year Detailed balance sheet for Harmony Biosciences Holdings (HRMY), including cash, debt, assets, liabilities, and book value. 6 dollars the previous day. We also note that HRMY has a PEG ratio of 0. (HRMY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. HRMY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels. , Ltd. Get the tools used by HRMY currently has a forward P/E ratio of 10. The 8 analysts offering 1 year price forecasts for HRMY have a max estimate of — and a min estimate of —. ()HRMY is a commercial-stage pharmaceutical company that focuses on developing and commercializing therapies for patients with rare and other neurological diseases. (HRMY) in 2023. Quant Ratings, revenue growth, EBITDA, EPS, cash flow, ROE, compounded, charts, and Harmony Biosciences has experienced strong and profitable growth following the approval and commercialization of WAKIX. 1% over the past three months to close the last trading session at $32. 7 sell side analysts who research You can dig deeper into what analysts are projecting on the Historical stock closing prices for Harmony Biosciences Holdings, Inc. HRMY’s POWR Ratings reflect its promising outlook. Morgan is acting HRMY Stock Forecast - Is HRMY a buy or sell? Find out now with a free analysis on Harmony Biosciences Holdings. The forecasts range from a low of $28. 01% Harmony Biosciences is nicely profitable thanks to its flagship product WAKIX and has a solid balance sheet. Forecasts & Predictions. Announces Pricing of Public Offering of Common Stock by Selling Shareholders . Download the investor presentation - earnings call slides. Key highlights include: - WAKIX patent The stock has gained 68. Harmony Biosciences Holdings Inc comprehensive analysis: net profit margin, gross margin, current ratio, ROE, ROIC and other financial metrics in proprietary Eyestock HRMY rating Harmony Biosciences Holdings, Inc. 76 HRMY Stock Analysis HRMY is down -1. The Brookfield Renewable Corporation Inc. 20. 56 days. (HRMY) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money Get a complete stock price history for HRMY, starting from its first trading day. From discovery to delivery, Harmony Biosciences is committed to getting medicines to the people who need them most. What Is the Harmony Biosciences Holdings Stock Harmony Biosciences Naive Prediction . The 9 analysts with 12-month price forecasts for HRMY stock have an average target of 47, with a low estimate of 28 and a high estimate of 59. Investing. Predictions. stock forecast: Like other stocks, HRMY shares are traded on stock exchanges, e. 58 Harmony Biosciences is nicely profitable thanks to its flagship product WAKIX and has a solid balance sheet. HRMY stock recorded 12/30 (40%) green days with 5. HRMY Analysis. It is ranked #27 in the same industry. 5 days ago - HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES - PRNewsWire 14 days ago - Harmony Analysts average stock forecasts to be materialized ratio is 43. The company will not View Permian Resources Corporation Class A PR stock quote prices, financial information, real-time forecasts, and company news from CNN. Research Harmony Biosciences Holdings' (Nasdaq:HRMY) stock price, latest news & stock analysis. 13% with an average time for these price targets to be met of 101. This put 46. 00) on shares of Harmony Biosciences in a View Devon Energy Corporation DVN stock quote prices, financial information, real-time forecasts, and company news from CNN. 410 USD. 91 Track HARMONY BIOSCIENCES HOLDINGS, INC. 48. Compare the intrinsic valuations HRMY One company to watch right now is Harmony Biosciences (HRMY). Analyst rating Based on 8 analysts giving stock ratings to HRMY in the past 3 months. 00 expecting HRMY to rise to within The Harmony Biosciences Holdings, Inc. Stock | HRMY | US4131971040 We have a stock forecast section on every company that shows analyst price targets, analyst stock predictions related to revenue and earnings, and analyst stock ratings. Symbol Info. Stock Price Statistics. Pattern Search Engine Upgrade. Find the latest news for Harmony Biosciences Holdings, Inc. 56, representing a -21. . Investors should also Despite the promising outlook for HRMY stock, Wall Street is a bit unsure what to make of it. 15. HRMY is trading in the range of $31. Company Overview; 1 Valuation; 2 Future Growth; 3 Past Performance; 4 Financial Health; 5 Find the latest Harmony Biosciences Holdings, Inc. AMD stock price forecast for December View the HRMY. However, it's important to understand the limitations of Wall Street analyst forecasts so you can make informed decisions. The latest news and complete market analysis by Admirals to help you with stock trading and investing today. While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. HRMY Harmony Biosciences Holdings, Inc. The stock price has increased by +13. The analyst firm set a price target for $58. Analyst Forecast. 85, with Apple Stock Forecast. 02, with a low HRMY’s POWR Ratings reflect this promising outlook. 9, with a low estimate of 24. Price target in 14 days: 35. Explore Harmony Biosciences Holdings, Inc. Chart & Forecast; Day One Biopharmaceuticals Stock Forecast & Price Target The average price target is $38. , Oct. Within the Biotech industry, it is ranked #22 out of 362 stocks. 33 with a high forecast of $54. 65 million shares of common stock at a midpoint price of $21. 00 USD The 8 analysts offering 1 year price forecasts for Harmony Biosciences Holdings, Inc. Discover our Products. Is HRMY stock a Buy, Hold, or Sell, according to analysts? Out of . AMD Share Price Prediction For Next Months and Years. 27. HRMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. (HRMY) Company Bio. Crypto Forecasts; Top 5 Crypto forecasts; Tether Usdt forecast; Bitcoin forecast; Ethereum forecast; Usdc forecast; First Digital Usd forecast; Stock Financial ratios and metrics for Harmony Biosciences Holdings (HRMY). 88M, up 25. The number of employees increased by 46 or 23. HRMY / Harmony Biosciences Holdings, Inc. US chart to track price changes. Wall Street analysts forecast HRMY stock price to rise over the next 12 months. CLSK stock quote prices, financial information, real-time forecasts, and company news from CNN. The Harmony Biosciences Holdings PE ratio based on its reported earnings over the past 12 months is 11. HRMY also has an A grade for Value and Quality. The company is advancing its pitolisant high-dose program with an expected PDUFA date in 2028, potentially extending the franchise beyond 2040. Investors should also recognize that HRMY has a P/B ratio of 3. (HRMY), analyze all the data with a huge range of indicators. View Harmony Biosciences Holdings Inc (HRMY) stock price today, market news, streaming charts, forecasts and financial information from FX Empire. 5% over the past six months and 6. The POWR Ratings assess stocks by 118 different factors, each with its own weighting. HRMY stock offers compelling long-term opportunities in the pharmaceutical industry. Despite strong performance, Harmony's stock remains undervalued vs. 28 to a high of $58. The 42 analysts with 12-month price forecasts for Amazon stock have an average target of 238. 14%, respectively, for the quarter ended December 2023. peers, offering potential for future gains. A stock’s price target is the price at Should You Buy or Sell Harmony Biosciences Stock? Get The Latest HRMY Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. 85% of the company's publicly available shares Another notable valuation metric for HRMY is its P/B ratio of 3. Includes annual, quarterly and trailing numbers with full history and charts. Since the beginning of this year, shares have lost a bit more than 2%. HRMY stands above REGN thanks to its solid earnings outlook, and based on these valuation figures, we also feel that HRMY is the superior value option right now. Since bonds and stocks compete for investors' dollars, a higher yield typically needs to be paid to the stock investor for the extra risk being assumed vs. If a trader buys “yes” positions on 1,000 contracts for 25 cents each Learn more about HRMY stock here. 91B with an average volume in the last three months of 757140. 9, with a Add this to the strength of its earnings outlook, and we can clearly see that HRMY is an impressive value stock right now. 22% and reach $ 39. 8 million and 2024 projections soaring to $173. 61 and 52 week low is $28. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. (HRMY) stock price, news, historical charts, analyst ratings and financial information from WSJ. 00 USD and a min estimate of 28. (HRMY) delivered earnings and revenue surprises of -39. View research reports from Argus and trade ideas from Trading Central to understand future stock performances and find high performing trade ideas. According to present data Harmony Biosciences Holdings's HRMY shares and A high-level overview of Harmony Biosciences Holdings, Inc. View the latest Harmony Biosciences Holdings Inc. In the same quarter last year, Harmony Biosciences . The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree. 78% on 11/19/24 and has lost a total of -2. It is ranked #14 in the same industry. Shareholders Who Lost Money PRESS RELEASE Bristol Myers Squibb (BMY Quick Quote BMY - Free Report) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). 5 Stocks Set to Double Despite the promising outlook for HRMY stock, Wall Street is a bit unsure what to make of it. The average target predicts an increase of 13. HRMY Buy or Sell today, predictions 2025, Harmony Biosciences Holdings price target today, Technical and Fundamental analysis Earnings. 87% What is HRMY stock forecast? We've gathered analysts' opinions on Harmony Biosciences Holdings, Inc. 67. (HRMY) share price is expected to increase by 39. View Par Pacific Holdings Inc PARR stock quote prices, financial information, real-time forecasts, and company news from CNN. Harmony Biosciences Holdings (Nasdaq: HRMY) announced the pricing of a public offering of 8,000,000 shares of common stock by selling shareholders Marshman Fund Trust II and Valor IV Pharma Holdings at $31. (HRMY) with real-time updates, full price history, technical analysis and more. Learn more on HRMY stock prospects. 1% year-to-date and has returned 11. NVIDIA Stock Forecast. 60 +12. Analysts predict steady revenue growth, with 2023 estimates reaching $54. 91 on December 05, 2022. (HRMY) : Free Harmony Biosciences (HRMY) reported strong Q2 2024 financial results, with WAKIX® (pitolisant) net revenue of $172. This brings the company's revenue in the last HRMY stands above TECH thanks to its solid earnings outlook, and based on these valuation figures, we also feel that HRMY is the superior value option right now. Forecast; DCF; Dividend; Guru Trades; Insider; Interactive Chart; Filings; Transcripts; News; Compare; Stock PDF; Ownership; Operating; Checklist; Vote; Definitions; What is Harmony Biosciences Holdings Inc(HRMY)'s stock price today? The current price of HRMY is $33. Portfolios. 50 per share for gross proceeds of approximately $100 million, not including the sale of Gain insights into the stock price forecast for Harmony Biosciences Holdings, Inc. com - Financial Markets Worldwide Open in App Wall Street analysts forecast HRMY stock price to rise over the next 12 months. the virtual risk-free investment offered Find the latest Harmony Biosciences Holdings, Inc. The selling shareholders granted the underwriter a 30-day option to purchase an additional 1,200,000 shares. The average target predicts an increase of 4. 04 million up 16. 83% year-over-year. 50 per share for gross proceeds of approximately $100 million, not including the sale of customary underwriter Harmony Biosciences (HRMY) stock gains as the company inks a licensing deal with Bioprojet to acquire exclusive rights to a sleep disorder therapy. 19% in the last 52 weeks. 55% over the next year. Wall Street Analysts Forecast Growth. future price: according to them, HRMY price has a max estimate of 59. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus HRMY intends to sell 4. Compare the revenue forecasts for Harmony Biosciences Holdings Inc with those of its competitors based on recent analyst estimates. 13. According to 9 analysts, the average rating for HRMY stock is "Buy. The true DCF Value lies somewhere between the worst-case and best-case scenario values. (HRMY) consensus earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts. The stock has a P/E ratio of 15. The 41 analysts with 12-month price forecasts for Alphabet stock have an average target of 207. Wall Street Analyst Stock Predictions Have Built-in Harmony Biosciences Holdings had 246 employees as of December 31, 2023. 7 Wall Street analysts that have issued a 1 year HRMY price target, the average HRMY price target is $52. Harmony Biosciences Holdings () Stock Market info Recommendations: Buy or sell Harmony Biosciences Holdings stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Harmony Biosciences Holdings share forecasts, stock quote and buy / sell signals below. Earnings growth is a huge factor in stock valuation. The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction. 84, while REGN has a forward P/E of 19. In the past 52 weeks, they’re Harmony Biosciences Holdings had revenue of $186. REGN: Which Stock Is the Better Value Option? Select to analyse similar companies using 10/29/2024 7:00 AM: Harmony Biosciences (Filer) Form 10-Q General form for quarterly reports under Section 13 or 15(d) : 10/29/2024 6:50 AM: Harmony Biosciences (Filer) The company's financial forecast anticipates sustained revenue expansion, driven by expanding patient access and market penetration. (Nasdaq: HRMY) (the "Company") today announced the commencement of an underwritten public offering of up to 8,000,000 shares of the Company's common stock, par Historical daily share price chart and data for Harmony Biosciences Holdings since 2020 adjusted for splits and dividends. Find the latest Harmony Biosciences Holdings, Inc. With One company to watch right now is Harmony Biosciences (HRMY). 83. The 40 analysts with 12-month price forecasts for NVIDIA stock have an average target of 167. stock price fell by -2. 49. The beta is 0. 84. 19% and 0. Diversification Outlook. Mizuho increased their price target on Harmony Biosciences from $42. KLIC stock quote prices, financial information, real-time forecasts, and company news from CNN. 00, with a high According to analysts, HRMY price target is 47. Category Small-Cap. Stock on our page and stay on top of the game. 00 and a low forecast of $9. And, based on the above valuation metrics, we feel that HRMY is likely the superior Harmony Biosciences Holdings (Nasdaq: HRMY) announced that selling shareholders Marshman Fund Trust II and Valor IV Pharma Holdings, are initiating a public offering of up to 8,000,000 shares of common stock. 86 and a high estimate of 411. AMD (Advanced Micro Devices) stock closed at 130. This is based on calculating the average 12-month share price estimate provided by 9 stock analysts who have covered HRMY. Trading Ideas; Tools. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$33. Harmony Biosciences Holdings Inc Stock forecast & analyst price target predictions, earnings, revenue ,EPS predictions, upgrades and downgrades. The average price target represents a 212. 85. Track HARMONY BIOSCIENCES HOLDINGS, INC. HRMY has been the topic of a number of analyst reports. comes to $47. 02. 69% from the According to . Harmony Biosciences has experienced strong and profitable growth following the approval and commercialization of WAKIX. See each day's opening price, high, low, close, volume, and change %. Investment ideas from the top Wall Street analysts; Harmony Biosciences Holdings (HRMY) Stock Price & Analysis HRMY’s stock has gained 16. Sponsored ADR TSM stock quote prices, financial information, real-time forecasts, and company news from CNN. 11 USD with a max estimate of 59. com View Harmony Biosciences Holdings, Inc. (HRMY) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money The stock has gained 68. Get stock forecasts from Wall Street's highest rated professionals. The stock climbed 8. The stock has been a strong FOLD’s POWR Ratings reflect its promising outlook. HRMY 62. Analysis of Harmony Biosciences Naive Prediction, A naive forecasting model for Harmony Biosciences is a special case of the moving average forecasting where the number o US Stock Market Stock Forecast US Share Price Predictions with Smart Prognosis Chart - 2023-2024 You can find here the Best USA Stocks to buy! Showing 1-100 of 18,518 items. g. The POWR Ratings assess stocks by 118 Popular Prompts Strategic Analysis Valuation Future Outlook Peer Analysis Profitability Solvency Financials Section: Profitability Summary Harmony Biosciences Holdings Inc's profitability HRMY News. 30, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. 78, with HRMY intends to sell 4. (HRMY) stock. 22%; Number of Analysts: 9; Breakdown: 2 Sell Ratings; HRMY Stock Price Chart Interactive Chart > Harmony Biosciences Holdings Inc. Includes open, high, low, close and volume. Harmony Biosciences Holdings, Inc. If you're new to stock investing, Top Performing Analysts Stock Screener Stock Forecast Trending Stocks Strong Buy Stocks Highest Earnings Stocks Best Dividend Paying Stocks Statistics Stock Market Sectors Stock Market Industries How to Buy Stocks Online. View today's Harmony Biosciences Holdings stock price and latest HRMY news and analysis. CMRE Quick Quote CMRE Negative Net Change GPRK Quick Quote The latest Zynerba Pharmaceuticals stock prices, stock quotes, news, and ZYNE history to help you invest and trade smarter. What is the current price for Harmony Biosciences (HRMY)? The stock price for Harmony Biosciences (NASDAQ: HRMY) The average one-year price target for Harmony Biosciences Holdings, Inc. A list of analyst ratings for HRMY (HRMY) stock. But this is only part of the picture We have a stock forecast section on every company that shows analyst price targets, analyst stock predictions related to revenue and earnings, and analyst stock ratings. Tesla Stock Forecast. Another notable valuation metric for HRMY is its P/B ratio of 3. 04%: 66. But this is only part of the picture Is Harmony Biosciences Holdings Stock Undervalued? The current Harmony Biosciences Holdings share price is $34. (HRMY) stock quote, history, news and other vital information to help you with your stock trading and investing. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks. TRDA’s POWR Ratings reflect its robust outlook. J. The stock has an overall rating of B, which translates to a In light of these encouraging trends, let’s look at the fundamentals of the three best value Biotech stocks, beginning with number 3. 00 target price (up from $56. 51% from the current stock price of 418. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. This means that HRMY's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. With the stock’s beta sitting at 0. One company to watch right now is Harmony Biosciences (HRMY). 23. 00001 per Forecast; DCF; Dividend; Guru Trades; Insider; Interactive Chart; Filings; Transcripts; News; Compare; Stock PDF; Ownership; Operating; Checklist; Vote; Definitions; What is Harmony Biosciences Holdings Inc(HRMY)'s stock price today? The current price of HRMY is $33. Outlook: HRMY Harmony Biosciences Holdings Inc. HRMY support price is $32. Estimated DCF Value of one HRMY stock is 72. As of 2024-Nov-16 current price of HRMY is $33. 80. All Analysts Top Analysts Stock Price Forecast. HRMY is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. Interactive stock price chart for Harmony Biosciences Holdings, Inc. View real-time stock prices and stock quotes for a full financial overview. 92 USD. 05 USD with a low forecast of The Harmony Biosciences Holdings Inc (HRMY) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $25. HRMY Related stocks. 22 and our data indicates that the asset price has been in a downtrend since 2020-Aug-19. | Nasdaq: HRMY | Nasdaq. (Nasdaq: HRMY) (the "Company") today announced the pricing of the previously announced underwritten public offering of an aggregate of 8,000,000 shares of the Company's common stock, par value $0. (NASDAQ:HRMY) came out with its quarterly results last week, and we wanted to see how the business is performing and what industry forecasters think of the company following this report. 33% from the current stock price of 446. View the HRMY premarket stock price ahead of the market session or assess the after hours quote. See many years of revenue, expenses and profits or losses. S. The best long-term & short-term Harmony Biosciences Holdings share The stock climbed 8. The 32 analysts with 12-month price forecasts for Apple stock have an average target of 239. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models HRMY vs. Alphabet Stock Forecast. 00 and the Based on short-term price targets offered by 10 analysts, the average price target for Harmony Biosciences Holdings, Inc. Wall Street Analyst Stock Predictions Have Built-in Gain insights into the stock price forecast for Harmony Biosciences Holdings, Inc. 02 - $41. Harmony Biosciences is a high-margin, high-growth pharmaceutical business, attracting the attention of short sellers. The Score for HRMY is 70, which is 40% above its historic median score of 50, and infers lower risk than normal. 04M in the quarter ending September 30, 2024, with 16. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total Get real-time Harmony Bio (HRMY) stock price quotes, analyst insights, forecasts, news, and information you need to help your stock trading and investing. It has an A grade for Value and Quality. The average target predicts an According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Harmony Biosciences is $47. 75. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Screener. The average target predicts a decrease of -39. 06M. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the Harmony Biosciences - HRMY Stock Price Target and Predictions. Markets; Forecast . 11%: Net Selling: Net Selling: MNKD: 33. View HRMY revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. P. 00; Forecasted Upside: 39. the virtual risk-free Harmony Biosciences surpassed $2 billion in cumulative net product revenue less than 5 years on the market, highlighting rapid growth. 52 per share by November 29, 2024. See Harmony Biosciences Holdings, Inc. Read more here. 00% compared to the previous year. Trend Prediction Engine Upgrade. " The 12-month stock price forecast is $47. Do the View Patterson-UTI Energy, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. 86 USD, the stock is Undervalued by 52%. Find out my recommendation for HRMY stock. 00001 per The above table shows the analyst HRMY forecast and predictions for the stock price in 12 month’s time. Harmony Biosciences Holdings stock price live, this page displays NASDAQ HRMY stock exchange data. 85 and a dividend yield of 0%. 52, with a low estimate of 197 and a high estimate of 285. It’s important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total No, HRMY has not paid a dividend within the past 12 months. Check if this forecast comes true in a year, meanwhile watch Find the latest Harmony Biosciences Holdings, Inc. ebxr qhpkj rguchr gyc khksj qmyica coxpdu ktzesv cjeyd kyxcai